Withdrawal Notice: Drug Repurposing for Prospective Anti-Cancer Agents Along with the Clinical Status of the Repurposed Drug

Autor: Sabale AS; Department of Pharmaceutical Quality Assurance, Sanjivani College of Pharmaceutical Education and Research, Kopargaon, M.S. India., Patel UM; Department of Pharmaceutical Quality Assurance, Sanjivani College of Pharmaceutical Education and Research, Kopargaon, M.S. India., Gorhe AA; Department of Pharmaceutical Quality Assurance, Sanjivani College of Pharmaceutical Education and Research, Kopargaon, M.S. India., Bodhankar VR; Department of Pharmaceutical Quality Assurance, Sanjivani College of Pharmaceutical Education and Research, Kopargaon, M.S. India., Shinde MN; Department of Pharmaceutical Quality Assurance, Sanjivani College of Pharmaceutical Education and Research, Kopargaon, M.S. India., Sonawane GA; Department of Pharmaceutics, Sanjivani College of Pharmaceutical Education and Research, Kopargaon, M.S. India., Raotole HS; Department of Pharmaceutics, Sanjivani College of Pharmaceutical Education and Research, Kopargaon, M.S. India., Pande RY; Department of Pharmaceutical Quality Assurance, Sanjivani College of Pharmaceutical Education and Research, Kopargaon, M.S. India., Kulkarni AD; Department of Pharmaceutical Quality Assurance, Sanjivani College of Pharmaceutical Education and Research, Kopargaon, M.S. India.

Publikováno v: Anti-cancer agents in medicinal chemistry [Anticancer Agents Med Chem] 2020 Jul 28. Date of Electronic Publication: 2020 Jul 28.